http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2826866-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f028281f3d001fea61a2bc72288984e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2826866-A1 |
titleOfInvention | MEST and MIR335/335* as biomarkers of mitochondrial diseases |
abstract | The present invention concerns an in vitro method of diagnosis or prognosis of a mitochondrial disease by detecting at least one of MEST, microRNA-335 or microRNA-335*, a precursor of said microRNA-335 and microRNA-335* and their use as biomarker of mitochondrial disease. The invention further concerns a ligand specifically binding to at least one of said biomarkers, for use for diagnosing or prognosing of a mitochondrial disease, a pair of primers suitable for amplifying a nucleic acid encoding for at least one of said biomarkers and the kit comprising such ligand and/or pair of primers. |
priorityDate | 2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.